No Increase in Chronic Pain Among Opioid-Dependent Individuals Randomized to Treatment With Extended-Release Naltrexone Compared to Buprenorphine-Naloxone

被引：1
|
作者：
Tanum, Lars [1 ]
Latif, Zill-E-Huma [1 ]
Solli, Kristin [1 ]
Opheim, Arild [2 ]
Kunoe, Nikolaj [3 ]
Benth, Jurate [3 ]
Krajci, Peter [4 ]
机构：
[1] Akershus Univ Hosp, Nordbyhagen, Norway
[2] Haukeland Hosp, Bergen, Norway
[3] Univ Oslo, Oslo, Norway
[4] Oslo Univ Hosp, Oslo, Norway
来源：
BIOLOGICAL PSYCHIATRY | 2019年 / 85卷 / 10期
关键词：
Opioid Use Disorder; Long-Acting Naltrexone; Chronic Pain; Buprenorphine;
D O I：
10.1016/j.biopsych.2019.03.535
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
T212
引用
收藏
页码：S211 / S212
页数：2
相关论文
共 50 条
  • [41] Initial Response as a Predictor of 12-Week Buprenorphine-Naloxone Treatment Response in a Prescription Opioid-Dependent Population
    McDermott, Katherine A.
    Griffin, Margaret L.
    Connery, Hilary S.
    Hilario, E. Yvette
    Fiellin, David A.
    Fitzmaurice, Garrett M.
    Weiss, Roger D.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (02) : 189 - 194
  • [42] Co-occurring Depression in Patients With Opioid Use Disorder: Prevalence and Response During Treatment With Buprenorphine-Naloxone or Extended- Release Naltrexone
    Na, Peter
    Scodes, Jennifer
    Pavlicova, Martina
    Fishman, Marc
    Rotrosen, John
    Nunes, Edward
    AMERICAN JOURNAL ON ADDICTIONS, 2021, 30 (03): : 253 - 253
  • [43] Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial
    Roache, John D.
    Pavlicova, Martina
    Campbell, Aimee
    Choo, Tse-Hwei
    Peavy, Michelle
    Kermack, Andrea S.
    Nunes, Edward V., Jr.
    Rotrosen, John
    ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, 2021, 45 (12): : 2569 - 2578
  • [44] Anxiety, Depression, and Insomnia Among Adults With Opioid Dependence Treated With Extended-Release Naltrexone vs Buprenorphine-Naloxone: A Randomized Clinical Trial and Follow-up Study (vol 76, pg 127, 2018)
    Latif, Z. E. H.
    Benth, Saltyte J.
    Solli, K. K.
    JAMA PSYCHIATRY, 2019, 76 (02) : 219 - 219
  • [45] Characteristics and treatment preferences of individuals with opioid use disorder seeking to transition from buprenorphine to extended-release naltrexone in a residential setting
    Mannelli, Paolo
    Douaihy, Antoine B.
    Akerman, Sarah C.
    Legedza, Anna
    Fratantonio, James
    Zavod, Abigail
    Sullivan, Maria A.
    AMERICAN JOURNAL ON ADDICTIONS, 2022, 31 (02): : 142 - 147
  • [46] Sublingual Buprenorphine-Naloxone Compared With Injection Naltrexone for Opioid Use Disorder: Potential Utility of Patient Characteristics in Guiding Choice of Treatment
    Nunes, Edward V., Jr.
    Scodes, Jennifer M.
    Pavlicova, Martina
    Lee, Joshua D.
    Novo, Patricia
    Campbell, Aimee N. C.
    Rotrosen, John
    AMERICAN JOURNAL OF PSYCHIATRY, 2021, 178 (07): : 660 - 671
  • [47] Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted Youth A Randomized Trial
    Woody, George E.
    Poole, Sabrina A.
    Subramaniam, Geetha
    Dugosh, Karen
    Bogenschutz, Michael
    Abbott, Patrick
    Patkar, Ashwin
    Publicker, Mark
    McCain, Karen
    Potter, Jennifer Sharpe
    Forman, Robert
    Vetter, Victoria
    McNicholas, Laura
    Blaine, Jack
    Lynch, Kevin G.
    Fudala, Paul
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 300 (17): : 2003 - 2011
  • [48] Benefits of Extended-Release Opioid Analgesic Formulations in the Treatment of Chronic Pain
    Nicholson, Bruce
    PAIN PRACTICE, 2009, 9 (01) : 71 - 81
  • [49] Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review
    Shirk, Steven D.
    Ameral, Victoria
    Kraus, Shane W.
    Houchins, Joseph
    Kelly, Megan
    Pugh, Kendra
    Reilly, Erin
    Desai, Nitigna
    JOURNAL OF DUAL DIAGNOSIS, 2021, 17 (03) : 207 - 215
  • [50] Adapting treatment length to opioid-dependent individuals' needs and preferences: a 2-year follow-up to a 1-year study of extended-release naltrexone
    Solli, Kristin Klemmetsby
    Opheim, Arild
    Latif, Zill-e-Huma
    Krajci, Peter
    Benth, Jurate S. altyte
    Kunoe, Nikolaj
    Tanum, Lars
    ADDICTION, 2021, 116 (08) : 2084 - 2093
12345